{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:31:07Z","timestamp":1718152267576},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,11]]},"DOI":"10.7759\/cureus.62126","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T08:20:13Z","timestamp":1718094013000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparison of Obstetric Outcomes in Antiphospholipid Syndrome Among Pregnant Women With Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Dur e","family":"Shahwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duriya","family":"Rehmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-03-0191","article-title":"Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study","volume":"112","author":"Ruffatti A","year":"2014","unstructured":"Ruffatti A, Salvan E, Del Ross T, et al.. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost. 2014, 112:727-35. 10.1160\/TH14-03-0191","journal-title":"Thromb Haemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000633","article-title":"Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')","volume":"9","author":"Erton ZB","year":"2022","unstructured":"Erton ZB, Sevim E, de Jes\u00fas GR, et al.. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus Sci Med. 2022, 9:e000633. 10.1136\/lupus-2021-000633","journal-title":"Lupus Sci Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22066","article-title":"Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature","volume":"65","author":"Andreoli L","year":"2013","unstructured":"Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken). 2013, 65:1869-73. 10.1002\/acr.22066","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2015.0085","article-title":"The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus","volume":"3","author":"\u00dcnl\u00fc O","year":"2016","unstructured":"\u00dcnl\u00fc O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol. 2016, 3:75-84. 10.5152\/eurjrheum.2015.0085","journal-title":"Eur J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000194205.95870.86","article-title":"Early risk factors for pregnancy loss in lupus","volume":"107","author":"Clowse ME","year":"2006","unstructured":"Clowse ME, Magder LS, Witter F, et al.. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006, 107:293-9. 10.1097\/01.AOG.0000194205.95870.86","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon JP","year":"2015","unstructured":"Buyon JP, Kim MY, Guerra MM, et al.. Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med. 2015, 163:153-63. 10.7326\/M14-2235","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181fe02ec","article-title":"Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis","volume":"116","author":"Do Prado AD","year":"2010","unstructured":"Do Prado AD, Piovesan DM, Staub HL, et al.. Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet Gynecol. 2010, 116:1433-1443. 10.1097\/AOG.0b013e3181fe02ec","journal-title":"Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler H","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, et al.. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016, 374:13-22. 10.1056\/NEJMoa1414838","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-007-0035-9","article-title":"Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?","volume":"9","author":"Clark EA","year":"2007","unstructured":"Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?. Curr Rheumatol Rep. 2007, 9:219-25. 10.1007\/s11926-007-0035-9","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2008.11.001","article-title":"Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes","volume":"79","author":"Yamada H","year":"2009","unstructured":"Yamada H, Atsumi T, Kobashi G, et al.. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol. 2009, 79:188-95. 10.1016\/j.jri.2008.11.001","journal-title":"J Reprod Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg MC","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725. 10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref14","article-title":"Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period","volume":"32","author":"Clark CA","year":"2005","unstructured":"Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005, 32:1709-12.","journal-title":"J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(19)30366-4","article-title":"Managing antiphospholipid syndrome in pregnancy","volume":"1016","author":"Schreiber K","unstructured":"Schreiber K, Hunt BJ. Managing antiphospholipid syndrome in pregnancy. Thromb Res. 2019 Sep. 1016:0049-3848. 10.1016\/S0049-3848(19)30366-4","journal-title":"Thromb Res. 2019 Sep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","volume":"3","author":"Yelnik CM","year":"2016","unstructured":"Yelnik CM, Laskin CA, Porter TF, et al.. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med. 2016, 3:e000131. 10.1136\/lupus-2015-000131","journal-title":"Lupus Sci Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11236984","article-title":"Anticoagulant therapy in patients with antiphospholipid syndrome","volume":"11","author":"Capecchi M","year":"2022","unstructured":"Capecchi M, Abbattista M, Ciavarella A, Uhr M, Novembrino C, Martinelli I. Anticoagulant therapy in patients with antiphospholipid syndrome. J Clin Med. 2022, 11:6984. 10.3390\/jcm11236984","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012852.pub2","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamuly\u00e1k EN","year":"2020","unstructured":"Hamuly\u00e1k EN, Scheres LJ, Marijnen MC, Goddijn M, Middeldorp S. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database Syst Rev. 2020, 5:CD012852. 10.1002\/14651858.CD012852.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-023-02834-6","article-title":"Positive antiphospholipid antibodies: observation or treatment?","volume":"56","author":"Grygiel-G\u00f3rniak B","year":"2023","unstructured":"Grygiel-G\u00f3rniak B, Mazurkiewicz \u0141. Positive antiphospholipid antibodies: observation or treatment?. J Thromb Thrombolysis. 2023, 56:301-14. 10.1007\/s11239-023-02834-6","journal-title":"J Thromb Thrombolysis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit JY","year":"2022","unstructured":"Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-Garc\u00eda A. Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep. 2022, 23:85. 10.1007\/s11926-021-01038-2","journal-title":"Curr Rheumatol Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311434939","article-title":"Maternal deaths in women with lupus nephritis: a review of published evidence","volume":"21","author":"Ritchie J","year":"2012","unstructured":"Ritchie J, Smyth A, Tower C, Helbert M, Venning M, Garovic V. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus. 2012, 21:534-41. 10.1177\/0961203311434939","journal-title":"Lupus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0377-1237(10)80121-2","article-title":"Bad obstetric history: a prospective study","volume":"66","author":"Singh G","year":"2010","unstructured":"Singh G, Sidhu K. Bad obstetric history: a prospective study. Med J Armed Forces India. 2010, 66:117-20. 10.1016\/S0377-1237(10)80121-2","journal-title":"Med J Armed Forces India"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.02.006","article-title":"The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis","volume":"128","author":"Abou-Nassar K","year":"2011","unstructured":"Abou-Nassar K, Carrier M, Ramsay T, Rodger MA. The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb Res. 2011, 128:77-85. 10.1016\/j.thromres.2011.02.006","journal-title":"Thromb Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000769","article-title":"Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?","volume":"9","author":"Fazzari MJ","year":"2022","unstructured":"Fazzari MJ, Guerra MM, Salmon J, Kim MY. Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?. Lupus Sci Med. 2022, 9:10.1136\/lupus-2022-000769","journal-title":"Lupus Sci Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13665","article-title":"The association between antiphospholipid antibodies and late fetal loss: a systematic review and meta-analysis","volume":"98","author":"Xu J","year":"2019","unstructured":"Xu J, Chen D, Duan X, Li L, Tang Y, Peng B. The association between antiphospholipid antibodies and late fetal loss: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2019, 98:1523-33. 10.1111\/aogs.13665","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255953-a-comparison-of-obstetric-outcomes-in-antiphospholipid-syndrome-among-pregnant-women-with-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T08:20:26Z","timestamp":1718094026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255953-a-comparison-of-obstetric-outcomes-in-antiphospholipid-syndrome-among-pregnant-women-with-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.62126","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,11]]}}}